← FDA Drug Approvals (Drugs@FDA)
RIVASTIGMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: YICHANG HUMANWELL · Approved 2025-09-23
Drug application
- FDA Application #
ANDA215445- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIVASTIGMINE
- Generic name
- Rivastigmine
- Active ingredients
- RIVASTIGMINE
- Dosage form
- FILM, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing status
- Prescription
- Sponsor
- YICHANG HUMANWELL
- First approval
- 2025-09-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown